Dave Johnson, CEO of VelosBio interviewed - Arix Bioscience

Close Navigation

About Arix Strategy

Overview Investment case News Results Documents Events Calendar Analysts Stock info Contact

About Strategy Team Portfolio Insights Media Contact

About Strategy Team Portfolio Insights Media Contact

Overlay

Dave Johnson, CEO of VelosBio interview

4th December 2019

Arix Bioscience

Investor Relations

Financial Calendar

Regulatory News

Document Library

Analysts & Advisors

Shareholder Information

Meta

Stay up to date

Sign up to receive regulatory news and results

Arix Bioscience plc, registered in England and Wales with company number 09777975

Registered office: Duke Street House, 50 Duke Street, London, W1K 6JL, United Kingdom

Website by Ether